Clinical & Market Approval

Your trial is driven by an unrivalled, powerful combination of data sources to inform decision-making. With intelligent recruitment, you can minimize study costs, speed time to market and increase forecasting accuracy. Gain timely, real-world LabCorp diagnostic lab result data, Covance Global Central Labs investigator performance data and patient intelligence input that provides unique insights – putting you on the right track to enjoy faster patient enrollment and enhanced patient retention.

When your trial is underway, you are fully armed withXcellate.® for a comprehensive risk-based quality management (RBQM) approach and enhanced visibility into your trial performance. You’ll enjoy near real-time holistic insights, allowing your study team to make informed decisions and proactively mitigate issues that may come up. This means you can reduce study risk, ensure data quality and gain operational insights – keeping your patients safe and helping you get your medical device to market successfully.

• 协议设计工具– accurately assess the number of people that meet your study criteria, model the data to
  maximize the available patient pool and pinpoint geographic clusters of people who fit the defined eligibility criteria.
• 患者智力- 使您可以设计更耐用的以患者为中心的审判，以改善患者的招聘和保留。
• Site list tool– inform data-driven decisions that can optimize patient enrollment, avoid costs associated with poor and non-performing sites and cut down on the unnecessary inclusion of additional countries.
• Recruitment modeling and forecasting– improves enrollment predictability and mitigates risk throughout a study to meet your patient recruitment and delivery milestones.
• Spatial cluster analysis– guides your selection of sites based on location of eligible patient clusters to improve study planning and accelerate patient enrollment.
• Patient direct– a direct-to-consumer recruitment model that can supplement your investigators’ databases.